Literature DB >> 14712066

Deregulated repression of c-Jun provides a potential link to its role in tumorigenesis.

Carsten Weiss1, Dirk Bohmann.   

Abstract

The transcription factor c-Jun cooperates with oncogenic alleles of ras in malignant transformation. Constitutively active Ras causes, via activation of mitogen activated protein kinases, phosphorylation of c-Jun which is essential for subsequent target gene activation and tumorigenesis. Studying the mechanisms controlling c-Jun activity we found that its transcription activation function is actively repressed by a presumably multimeric repressor complex that includes histone deacetylase 3 as a critical subunit. Suppression of c-Jun is relieved by MAP kinase-mediated phosphorylation and/or titration of inhibitor components. The viral tumorigenic counterpart of c-Jun, v-Jun, escapes this inhibition, suggesting deregulated transcriptional activity of c-Jun as a relevant cause for carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14712066

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  15 in total

1.  Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis.

Authors:  Xiangli Cui; Yu Jin; Deepak Poudyal; Alexander A Chumanevich; Tia Davis; Anthony Windust; Anne Hofseth; Wensong Wu; Joshua Habiger; Edsel Pena; Patricia Wood; Mitzi Nagarkatti; Prakash S Nagarkatti; Lorne Hofseth
Journal:  Carcinogenesis       Date:  2010-08-20       Impact factor: 4.944

2.  TCR stimulation upregulates MS4a4B expression through induction of AP-1 transcription factor during T cell activation.

Authors:  Yaping Yan; Guang-Xian Zhang; Mark S Williams; Gregory B Carey; Hongmei Li; Jingxian Yang; Abdolmohamad Rostami; Hui Xu
Journal:  Mol Immunol       Date:  2012-05-16       Impact factor: 4.407

3.  12 Arylstibonic acids that inhibit the DNA binding of five B-ZIP dimers.

Authors:  Vikas Rishi; Won-Jun Oh; Sarah L Heyerdahl; Jianfei Zhao; Dominic Scudiero; Robert H Shoemaker; Charles Vinson
Journal:  J Struct Biol       Date:  2010-02-20       Impact factor: 2.867

4.  Specific c-Jun target genes in malignant melanoma.

Authors:  Patrick Schummer; Silke Kuphal; Lily Vardimon; Anja K Bosserhoff; Melanie Kappelmann
Journal:  Cancer Biol Ther       Date:  2016-04-06       Impact factor: 4.742

5.  P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformation.

Authors:  Tingting Li; Jishuai Zhang; Feng Zhu; Weihong Wen; Tatyana Zykova; Xiang Li; Kangdong Liu; Cong Peng; Weiya Ma; Guozheng Shi; Ziming Dong; Ann M Bode; Zigang Dong
Journal:  Carcinogenesis       Date:  2010-12-22       Impact factor: 4.944

6.  Identification of a novel phosphorylation site in c-jun directly targeted in vitro by protein kinase D.

Authors:  Richard T Waldron; Julian P Whitelegge; Kym F Faull; Enrique Rozengurt
Journal:  Biochem Biophys Res Commun       Date:  2007-03-05       Impact factor: 3.575

7.  COOH-terminal Src kinase-mediated c-Jun phosphorylation promotes c-Jun degradation and inhibits cell transformation.

Authors:  Feng Zhu; Bu Young Choi; Wei-Ya Ma; Zhongliang Zhao; Yiguo Zhang; Yong Yeon Cho; Hong Seok Choi; Akira Imamoto; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

8.  Benzo(a)pyrene-caused increased G1-S transition requires the activation of c-Jun through p53-dependent PI-3K/Akt/ERK pathway in human embryo lung fibroblasts.

Authors:  Shi Jiao; Bingci Liu; Ai Gao; Meng Ye; Xiaowei Jia; Fengmei Zhang; Haifeng Liu; Xianglin Shi; Chuanshu Huang
Journal:  Toxicol Lett       Date:  2008-03-27       Impact factor: 4.372

9.  Alpha-linolenic acid regulates Cox2/VEGF/MAP kinase pathway and decreases the expression of HPV oncoproteins E6/E7 through restoration of p53 and Rb expression in human cervical cancer cell lines.

Authors:  Rashmi Deshpande; Prakash Mansara; Ruchika Kaul-Ghanekar
Journal:  Tumour Biol       Date:  2015-10-06

10.  Analysis of Drosophila segmentation network identifies a JNK pathway factor overexpressed in kidney cancer.

Authors:  Jiang Liu; Murad Ghanim; Lei Xue; Christopher D Brown; Ivan Iossifov; Cesar Angeletti; Sujun Hua; Nicolas Nègre; Michael Ludwig; Thomas Stricker; Hikmat A Al-Ahmadie; Maria Tretiakova; Robert L Camp; Montse Perera-Alberto; David L Rimm; Tian Xu; Andrey Rzhetsky; Kevin P White
Journal:  Science       Date:  2009-01-22       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.